InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Cumming John W, 董事. Director active across 1 company, notably T2 Biosystems, Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €18k. History available since 1 July 2021. The latest transaction was filed on 1 July 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
John W. Cumming is a Board Member at T2 Biosystems, Inc. In this role, he contributes to the governance of the company by bringing his expertise in the health technology sector. John plays a key role in evaluating growth strategies and overseeing development initiatives. His industry experience is a valuable asset to T2 Biosystems' management team.